179 related articles for article (PubMed ID: 35563828)
1. Notch2 Blockade Mitigates Methotrexate Chemotherapy-Induced Bone Loss and Marrow Adiposity.
Peymanfar Y; Su YW; Xian CJ
Cells; 2022 May; 11(9):. PubMed ID: 35563828
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Targeting Notch2 Protects Bone Micro-Vasculatures from Methotrexate Chemotherapy-Induced Adverse Effects in Rats.
Peymanfar Y; Su YW; Hassanshahi M; Xian CJ
Cells; 2022 Aug; 11(15):. PubMed ID: 35954226
[TBL] [Abstract][Full Text] [Related]
3. Attenuated Wnt/β-catenin signalling mediates methotrexate chemotherapy-induced bone loss and marrow adiposity in rats.
Georgiou KR; King TJ; Scherer MA; Zhou H; Foster BK; Xian CJ
Bone; 2012 Jun; 50(6):1223-33. PubMed ID: 22484100
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate treatment suppresses osteoblastic differentiation by inducing Notch2 signaling and blockade of Notch2 rescues osteogenesis by preserving Wnt/β-catenin signaling.
Peymanfar Y; Su YW; Hassanshahi M; Xian CJ
J Orthop Res; 2022 Oct; 40(10):2258-2270. PubMed ID: 34935186
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate-induced bone marrow adiposity is mitigated by folinic acid supplementation through the regulation of Wnt/β-catenin signalling.
Georgiou KR; Nadhanan RR; Fan CM; Xian CJ
J Cell Physiol; 2015 Mar; 230(3):648-56. PubMed ID: 25187349
[TBL] [Abstract][Full Text] [Related]
6. miR-542-3p Attenuates Bone Loss and Marrow Adiposity Following Methotrexate Treatment by Targeting sFRP-1 and Smurf2.
Zhang YL; Liu L; Su YW; Xian CJ
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681655
[TBL] [Abstract][Full Text] [Related]
7. β-Catenin signaling is important for osteogenesis and hematopoiesis recovery following methotrexate chemotherapy in rats.
Fan J; Su YW; Hassanshahi M; Fan CM; Peymanfar Y; Piergentili A; Del Bello F; Quaglia W; Xian CJ
J Cell Physiol; 2021 May; 236(5):3740-3751. PubMed ID: 33078406
[TBL] [Abstract][Full Text] [Related]
8. Supplementation with fish oil and genistein, individually or in combination, protects bone against the adverse effects of methotrexate chemotherapy in rats.
Raghu Nadhanan R; Skinner J; Chung R; Su YW; Howe PR; Xian CJ
PLoS One; 2013; 8(8):e71592. PubMed ID: 23951199
[TBL] [Abstract][Full Text] [Related]
9. Prevention of bone growth defects, increased bone resorption and marrow adiposity with folinic acid in rats receiving long-term methotrexate.
Fan CM; Foster BK; Hui SK; Xian CJ
PLoS One; 2012; 7(10):e46915. PubMed ID: 23071661
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate chemotherapy reduces osteogenesis but increases adipogenic potential in the bone marrow.
Georgiou KR; Scherer MA; Fan CM; Cool JC; King TJ; Foster BK; Xian CJ
J Cell Physiol; 2012 Mar; 227(3):909-18. PubMed ID: 21503894
[TBL] [Abstract][Full Text] [Related]
11. Potential Effects of Phytoestrogen Genistein in Modulating Acute Methotrexate Chemotherapy-Induced Osteoclastogenesis and Bone Damage in Rats.
King TJ; Shandala T; Lee AM; Foster BK; Chen KM; Howe PR; Xian CJ
Int J Mol Sci; 2015 Aug; 16(8):18293-311. PubMed ID: 26258775
[TBL] [Abstract][Full Text] [Related]
12. Fish oil in comparison to folinic acid for protection against adverse effects of methotrexate chemotherapy on bone.
Raghu Nadhanan R; Fan CM; Su YW; Howe PR; Xian CJ
J Orthop Res; 2014 Apr; 32(4):587-96. PubMed ID: 24346859
[TBL] [Abstract][Full Text] [Related]
13. Effects of Resveratrol Supplementation on Methotrexate Chemotherapy-Induced Bone Loss.
Lee AM; Shandala T; Soo PP; Su YW; King TJ; Chen KM; Howe PR; Xian CJ
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28282956
[TBL] [Abstract][Full Text] [Related]
14. miR-6315 Attenuates Methotrexate Treatment-Induced Decreased Osteogenesis and Increased Adipogenesis Potentially through Modulating TGF-β/Smad2 Signalling.
Zhang YL; Liu L; Su YW; Xian CJ
Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944742
[TBL] [Abstract][Full Text] [Related]
15. Antisense oligonucleotides targeting
Canalis E; Grossman TR; Carrer M; Schilling L; Yu J
J Biol Chem; 2020 Mar; 295(12):3952-3964. PubMed ID: 31992595
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate chemotherapy promotes osteoclast formation in the long bone of rats via increased pro-inflammatory cytokines and enhanced NF-κB activation.
King TJ; Georgiou KR; Cool JC; Scherer MA; Ang ES; Foster BK; Xu J; Xian CJ
Am J Pathol; 2012 Jul; 181(1):121-9. PubMed ID: 22642908
[TBL] [Abstract][Full Text] [Related]
17. Folinic acid attenuates methotrexate chemotherapy-induced damages on bone growth mechanisms and pools of bone marrow stromal cells.
Xian CJ; Cool JC; Scherer MA; Fan C; Foster BK
J Cell Physiol; 2008 Mar; 214(3):777-85. PubMed ID: 17786974
[TBL] [Abstract][Full Text] [Related]
18. Individual or combination treatments with lapatinib and paclitaxel cause potential bone loss and bone marrow adiposity in rats.
Lee AMC; Bowen JM; Su YW; Plews E; Chung R; Keefe DMK; Xian CJ
J Cell Biochem; 2019 Mar; 120(3):4180-4191. PubMed ID: 30260048
[TBL] [Abstract][Full Text] [Related]
19. Retracted: Icariin attenuates methotrexate chemotherapy-induced bone marrow microvascular damage and bone loss in rats.
Hassanshahi M; Su YW; Khabbazi S; Fan CM; Tang Q; Wen X; Fan J; Chen KM; Xian CJ
J Cell Physiol; 2019 Sep; 234(9):16549-16561. PubMed ID: 30784063
[TBL] [Abstract][Full Text] [Related]
20. Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment.
Fan C; Cool JC; Scherer MA; Foster BK; Shandala T; Tapp H; Xian CJ
Bone; 2009 Jan; 44(1):61-70. PubMed ID: 18976724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
